{"id":38777,"date":"2020-04-02T00:00:00","date_gmt":"2020-04-01T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/"},"modified":"2020-11-16T16:21:25","modified_gmt":"2020-11-16T15:21:25","slug":"expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/","title":{"rendered":"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2"},"content":{"rendered":"<p>Investigadores del IBEC liderados por la profesora de investigaci\u00f3n ICREA N\u00faria Montserrat, en colaboraci\u00f3n con expertos internacionales, han identificado un f\u00e1rmaco capaz de bloquear los efectos del virus SARS-Co-V2, origen de la enfermedad del Coronavirus 2019.<\/p>\n<p>En el estudio, publicado hoy en la prestigiosa revista Cell, \u2013y en el que ha participado el Instituto Karolinska de Suecia, el Institute of Molecular Biotechnology de la Austrian Academy of Sciences y el Life Sciences Institute (LSI) de la Universidad of British Columbia, entre otros\u2013 los cient\u00edficos utilizaron minirri\u00f1ones desarrollados a partir de c\u00e9lulas madre humanas generados en el IBEC por el equipo <a href=\"http:\/\/www.ibecbarcelona.eu\/es\/research-groups\/pluripotency-for-organ-regeneration\/\" target=\"_blank\" rel=\"noopener noreferrer\">Pluripotencia para la regeneraci\u00f3 nde \u00f3rganos<\/a>, liderado por N\u00faria Montserrat.<\/p>\n<p>En estos organoides generados mediante t\u00e9cnicas de bioingenier\u00eda se ha descifrado c\u00f3mo el SARS-Co-V2 interacciona e infecta las c\u00e9lulas humanas del ri\u00f1\u00f3n.<\/p>\n<p>Estos organoides, creados mediante t\u00e9cnicas de bioingenier\u00eda, recogen la complejidad del \u00f3rgano real, lo que les ha permitido descifrar c\u00f3mo el SARS-Co-V2 interacciona e infecta las c\u00e9lulas humanas del ri\u00f1\u00f3n, adem\u00e1s de identificar una terapia dirigida a reducir su carga viral.<\/p>\n<p>\u201cEl uso de organoides humanos nos permite probar de manera muy \u00e1gil los tratamientos que ya se est\u00e1n utilizando para otras enfermedades o que est\u00e1n cerca de ser validados. En estos momentos en los que el tiempo apremia, estas estructuras 3D ahorran dr\u00e1sticamente el tiempo que destinar\u00edamos para probar un nuevo medicamento en humanos\u201d, destaca \u00a0N\u00faria Montserrat.\u00a0<\/p>\n<p><strong>\u25ba Art\u00edculo de referencia :<\/strong> Monteil et al. \u00ab<a href=\"https:\/\/www.cell.com\/pb-assets\/products\/coronavirus\/CELL_CELL-D-20-00739.pdf\" style=\"font-weight: 200\" target=\"_blank\" rel=\"noopener noreferrer\">Inhibition of SARS-CoV-2 infections in engineered human<\/a> <a href=\"https:\/\/www.cell.com\/pb-assets\/products\/coronavirus\/CELL_CELL-D-20-00739.pdf\" style=\"font-weight: 200\" target=\"_blank\" rel=\"noopener noreferrer\">tissues using clinical-grade soluble human ACE2<\/a>\u00ab. Cell 2020, DOI: 10.1016\/j.cell.2020.04.004<\/p>\n<p><strong>\u25ba M\u00e1s informaci\u00f3n: <a href=\"http:\/\/www.ibecbarcelona.eu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-de-la-enfermedad-del-coronavirus\/\" target=\"_blank\" rel=\"noopener noreferrer\">web del IBEC [+]<\/a><\/strong><\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investigadores del Instituto de Bioingenier\u00eda de Catalunya (<a href=\"http:\/\/www.pcb.ub.edu\/portal\/es\/cerca?p_p_id=cercador_WAR_empleatsempresesportlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;p_p_col_id=column-1&amp;p_p_col_count=1&amp;_cercador_WAR_empleatsempresesportlet_jspPage=%2Fhtml%2Fcommon%2Fdetall-empresa.jsp&amp;_cercador_WAR_empleatsempresesportlet_empresaId=ENT_000134&amp;_cercador_WAR_empleatsempresesportlet_redirect=%2Fportal%2Fca%2Fcerca%3Fp_p_id%3Dcercador_WAR_empleatsempresesportlet%26p_p_lifecycle%3D0%26p_p_mode%3Dview%26_cercador_WAR_empleatsempresesportlet_tab%3D1%26_cercador_WAR_empleatsempresesportlet_keywords%3Dibec\" target=\"_blank\" rel=\"noopener noreferrer\">IBEC<\/a>) en el Parc Cient\u00edfic de Barcelona han identificado un f\u00e1rmaco capaz de bloquear los efectos del virus SARS-Co-V2, origen de la enfermedad del Coronavirus 2019. El tratamiento, que desde hoy se podr\u00e1 probar en doscientos pacientes de Covid-19, ha demostrado su eficacia en minirri\u00f1ones generados a partir de c\u00e9lulas madre humanas.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"author":1,"featured_media":25598,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-38777","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sin-categorizar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2 - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2 - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Investigadores del Instituto de Bioingenier\u00eda de Catalunya (IBEC) en el Parc Cient\u00edfic de Barcelona han identificado un f\u00e1rmaco capaz de bloquear los efectos del virus SARS-Co-V2, origen de la enfermedad del Coronavirus 2019. El tratamiento, que desde hoy se podr\u00e1 probar en doscientos pacientes de Covid-19, ha demostrado su eficacia en minirri\u00f1ones generados a partir de c\u00e9lulas madre humanas. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-01T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-16T15:21:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/04\/16049219485fa92a5c387d8.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"680\" \/>\n\t<meta property=\"og:image:height\" content=\"453\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2\",\"datePublished\":\"2020-04-01T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:21:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/\"},\"wordCount\":304,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/16049219485fa92a5c387d8.jpeg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/\",\"name\":\"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2 - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/16049219485fa92a5c387d8.jpeg\",\"datePublished\":\"2020-04-01T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:21:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/16049219485fa92a5c387d8.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/16049219485fa92a5c387d8.jpeg\",\"width\":680,\"height\":453},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2 - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/","og_locale":"es_ES","og_type":"article","og_title":"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2 - Parc Cient\u00edfic de Barcelona","og_description":"Investigadores del Instituto de Bioingenier\u00eda de Catalunya (IBEC) en el Parc Cient\u00edfic de Barcelona han identificado un f\u00e1rmaco capaz de bloquear los efectos del virus SARS-Co-V2, origen de la enfermedad del Coronavirus 2019. El tratamiento, que desde hoy se podr\u00e1 probar en doscientos pacientes de Covid-19, ha demostrado su eficacia en minirri\u00f1ones generados a partir de c\u00e9lulas madre humanas. \u00a0","og_url":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2020-04-01T23:00:00+00:00","article_modified_time":"2020-11-16T15:21:25+00:00","og_image":[{"width":680,"height":453,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/04\/16049219485fa92a5c387d8.jpeg","type":"image\/jpeg"}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"adminpcb","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2","datePublished":"2020-04-01T23:00:00+00:00","dateModified":"2020-11-16T15:21:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/"},"wordCount":304,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/04\/16049219485fa92a5c387d8.jpeg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/","url":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/","name":"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2 - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/04\/16049219485fa92a5c387d8.jpeg","datePublished":"2020-04-01T23:00:00+00:00","dateModified":"2020-11-16T15:21:25+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/04\/16049219485fa92a5c387d8.jpeg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2020\/04\/16049219485fa92a5c387d8.jpeg","width":680,"height":453},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/expertos-del-ibec-contribuyen-a-identificar-un-farmaco-en-fase-clinica-que-bloquea-los-efectos-del-virus-sars-co-v2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Expertos del IBEC contribuyen a identificar un f\u00e1rmaco en fase cl\u00ednica que bloquea los efectos del virus SARS-Co-V2"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=38777"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38777\/revisions"}],"predecessor-version":[{"id":44887,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38777\/revisions\/44887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/25598"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=38777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=38777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=38777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}